Certara, Inc.

How big is Certara, Inc.?

As of Jun 18, Certara, Inc. has a market capitalization of 1,714.81 million, with net sales of 394.49 million and a net profit of -2.62 million over the latest four quarters.

Market Cap: As of Jun 18, Certara, Inc. has a market capitalization of 1,714.81 million, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Certara, Inc. reported net sales of 394.49 million and a net profit of -2.62 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 1,058.66 million and total assets of 1,575.10 million.

What does Certara, Inc. do?

Certara, Inc. is a small-cap software company specializing in drug development and regulatory science, with recent net sales of $106 million and a net profit of $5 million. It has a market cap of approximately $1.71 billion, a P/E ratio of 170, and a debt-to-equity ratio of 0.11.

Overview: <BR>Certara, Inc. operates in the software products industry and is categorized as a small-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 106 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 5 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 1,714.81 Million (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 170.00 <BR>Debt Equity: 0.11 <BR>Return on Equity: 1.03% <BR>Price to Book: 1.58 <BR><BR>Contact Details: <BR>Registrar Address: Not available.

Should I buy, sell or hold Certara, Inc.?

Is Certara, Inc. overvalued or undervalued?

As of August 6, 2025, Certara, Inc. is considered undervalued with a PEG ratio of 0.63 and a high P/E ratio of 170, despite underperforming the S&P 500 with a 1-year return of 7.87%.

As of 6 August 2025, Certara, Inc. has moved from a risky to an attractive valuation grade. The company appears to be undervalued, particularly when considering its PEG ratio of 0.63, which suggests growth potential relative to its price, alongside a P/E ratio of 170 and an EV to EBITDA ratio of 22.24. In comparison to peers, Certara's P/E is significantly higher than ACI Worldwide, Inc. at 25.62, indicating a premium valuation, yet its PEG ratio is more favorable than that of Aurora Innovation, Inc., which has a PEG of 0.00.<BR><BR>Despite the attractive valuation grade, Certara's recent stock performance has lagged behind the S&P 500, with a 1-year return of 7.87% compared to the S&P's 17.14%. This underperformance over the past year may suggest that the market has not fully recognized the company's growth potential, reinforcing the notion that Certara is currently undervalued.

Is Certara, Inc. technically bullish or bearish?

As of October 31, 2025, Certara, Inc. shows a mildly bullish trend with positive momentum indicators, but has underperformed the S&P 500 recently, returning -7.67% and -11.63% over the past week and month, respectively, while year-to-date it has gained 8.45% compared to the S&P 500's 16.30%.

As of 31 October 2025, the technical trend for Certara, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The daily moving averages are also mildly bullish, supporting this stance. However, the Bollinger Bands show a mixed signal with a weekly bullish and monthly mildly bearish outlook. The RSI does not provide any signals for both weekly and monthly periods. Overall, the strength of the bullish trend is moderate.<BR><BR>In terms of performance, Certara has underperformed the S&P 500 over the past week and month, with returns of -7.67% and -11.63% compared to the S&P 500's gains of 0.71% and 1.92%, respectively. However, it has shown a positive return of 8.45% year-to-date, although this is still below the S&P 500's 16.30% return.